Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
13 02 2023
Historique:
received: 24 02 2022
revised: 08 07 2022
accepted: 24 07 2022
pubmed: 12 8 2022
medline: 16 2 2023
entrez: 11 8 2022
Statut: ppublish

Résumé

Alzheimer's disease is the most common neurodegenerative disease, characterized by dementia and premature death. Early-onset familial Alzheimer's disease is caused in part by pathogenic variants in presenilin 1 (PSEN1) and presenilin 2 (PSEN2), and alternative splicing of these two genes has been implicated in both familial and sporadic Alzheimer's disease. Here, we leveraged targeted isoform-sequencing to characterize thousands of complete PSEN1 and PSEN2 transcripts in the prefrontal cortex of individuals with sporadic Alzheimer's disease, familial Alzheimer's disease (carrying PSEN1 and PSEN2 variants), and controls. Our results reveal alternative splicing patterns of PSEN2 specific to sporadic Alzheimer's disease, including a human-specific cryptic exon present in intron 9 of PSEN2 as well as a 77 bp intron retention product before exon 6 that are both significantly elevated in sporadic Alzheimer's disease samples, alongside a significantly lower percentage of canonical full-length PSEN2 transcripts versus familial Alzheimer's disease samples and controls. Both alternatively spliced products are predicted to generate a prematurely truncated PSEN2 protein and were corroborated in an independent cerebellum RNA-sequencing dataset. In addition, our data in PSEN variant carriers is consistent with the hypothesis that PSEN1 and PSEN2 variants need to produce full-length but variant proteins to contribute to the onset of Alzheimer's disease, although intriguingly there were far fewer full-length transcripts carrying pathogenic alleles versus wild-type alleles in PSEN2 variant carriers. Finally, we identify frequent RNA editing at Alu elements present in an extended 3' untranslated region in PSEN2. Overall, this work expands the understanding of PSEN1 and PSEN2 variants in Alzheimer's disease, shows that transcript differences in PSEN2 may play a role in sporadic Alzheimer's disease, and suggests novel mechanisms of Alzheimer's disease pathogenesis.

Identifiants

pubmed: 35949106
pii: 6660735
doi: 10.1093/brain/awac294
pmc: PMC10169283
doi:

Substances chimiques

Amyloid beta-Protein Precursor 0
Presenilin-2 0
Presenilin-1 0
PSEN2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-518

Subventions

Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG018023
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032990
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007454
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG066567
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS080820
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066509
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG019610
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG017216
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG046139
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS122766
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG003949
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS072026
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Cell. 2016 Jun 30;166(1):193-208
pubmed: 27293189
Nature. 1991 Feb 21;349(6311):704-6
pubmed: 1671712
Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):433-5
pubmed: 24463146
Nat Rev Neurosci. 2004 May;5(5):347-60
pubmed: 15100718
Med Res Rev. 2020 Jan;40(1):431-458
pubmed: 31328804
PLoS One. 2012;7(2):e31039
pubmed: 22312439
EMBO J. 2012 May 16;31(10):2261-74
pubmed: 22505025
Science. 1995 Aug 18;269(5226):973-7
pubmed: 7638622
Sci Data. 2018 Sep 11;5:180185
pubmed: 30204156
RNA. 2008 Oct;14(10):2050-60
pubmed: 18719245
Acta Neuropathol. 2012 Sep;124(3):305-23
pubmed: 22618995
Neurobiol Aging. 2016 Jan;37:208.e11-208.e17
pubmed: 26522186
Ann Clin Transl Neurol. 2019 Mar 10;6(4):762-777
pubmed: 31020001
EMBO Rep. 2007 Feb;8(2):141-6
pubmed: 17268505
Cell Death Differ. 2003 Jun;10(6):698-708
pubmed: 12761578
J Alzheimers Dis. 2021;80(4):1479-1489
pubmed: 33720885
Brain. 2010 Apr;133(Pt 4):1143-54
pubmed: 20375137
Neuron. 2016 Apr 20;90(2):410-6
pubmed: 27100199
PLoS Med. 2017 Mar 28;14(3):e1002270
pubmed: 28350801
Front Genet. 2019 Jul 09;10:584
pubmed: 31338105
J Biol Chem. 2014 Nov 7;289(45):31043-52
pubmed: 25239621
Hum Mol Genet. 2015 Jul 1;24(13):3662-78
pubmed: 25814654
Science. 2020 Sep 11;369(6509):1318-1330
pubmed: 32913098
J Alzheimers Dis. 2018;64(s1):S161-S189
pubmed: 29865057
Neuron. 2021 May 19;109(10):1675-1691.e9
pubmed: 33848474
Brain Res Mol Brain Res. 2004 Aug 23;127(1-2):128-35
pubmed: 15306129
Receptors Clin Investig. 2015;2(1):e449
pubmed: 25646163
Alzheimers Dement. 2016 Jun;12(6):733-48
pubmed: 27016693
Curr Opin Neurol. 2010 Aug;23(4):394-400
pubmed: 20610990
J Alzheimers Dis. 2020;77(2):675-688
pubmed: 32741831
Nat Rev Dis Primers. 2015 Oct 15;1:15056
pubmed: 27188934
Eur J Hum Genet. 2016 May;24(5):710-6
pubmed: 26242991
Sci Data. 2016 Oct 11;3:160089
pubmed: 27727239
J Neurochem. 1999 Jun;72(6):2498-505
pubmed: 10349860
PLoS One. 2010 Dec 29;5(12):e15743
pubmed: 21206757
Arch Neurol. 2002 Nov;59(11):1737-46
pubmed: 12433261
Science. 2010 Nov 19;330(6007):1065
pubmed: 20929727
Exp Cell Res. 2011 Jul 1;317(11):1503-12
pubmed: 21530505
Neurobiol Dis. 2020 Jun;139:104817
pubmed: 32087291
Mol Psychiatry. 2012 Sep;17(9):875-9
pubmed: 22472873
Cell. 2017 Jul 27;170(3):443-456.e14
pubmed: 28753424
Nature. 1995 Jun 29;375(6534):754-60
pubmed: 7596406
J Neurochem. 2013 Dec;127(5):592-9
pubmed: 23952003
Trends Biochem Sci. 2010 Jul;35(7):377-83
pubmed: 20382028

Auteurs

Meredith M Course (MM)

Division of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Department of Molecular Biology, Colorado College, Colorado Springs, CO 80903, USA.

Kathryn Gudsnuk (K)

Division of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.

C Dirk Keene (CD)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Thomas D Bird (TD)

Division of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Northwest Mental Illness Research, Education and Clinical Centers, VA Puget Sound Health Care System, Seattle, WA 98108, USA.
Geriatrics Research Education and Clinical Center, Puget Sound VA Medical Center, Seattle, WA 98108, USA.
Department of Neurology, University of Washington School of Medicine, Seattle, WA 98195, USA.

Suman Jayadev (S)

Division of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.
Department of Neurology, University of Washington School of Medicine, Seattle, WA 98195, USA.

Paul N Valdmanis (PN)

Division of Medical Genetics, University of Washington School of Medicine, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH